-
Risk managers across the country cheered when they heard of dramatic decrease in the number of malpractice lawsuits filed in Tennessee after reform efforts there, wondering if the same experience might be replicated in their own states.
-
A young girl was brought to a hospital for an infection following the removal of her appendix and was admitted to the pediatric intensive care unit. An antifungal drug suitable for children was prescribed, but due to an alleged pharmacy error, the adult version of the drug was dispensed and administered. The girl had an adverse reaction to the drug and suffers from post-traumatic stress disorder (PTSD).
-
A pregnant woman presented to a hospital emergency department (ED) for delivery of her third child. Because of her high-risk pregnancy, the woman was scheduled for a cesarean. The cesarean was performed, followed by a hysterectomy. However, complications arose during the hysterectomy, and the woman slipped into a coma and died three days later.
-
To comply with the reporting requirements of MMSEA Section 111, an affected health care provider must first register with the Centers for Medicare & Medicaid Services (CMS) Coordination of Benefits Contractor (COBC).
-
If your health care organization is self-insured, the government is holding up a new hoop and waiting for you to jump through it.
-
Risk managers who take a good look at their organization's psychiatric treatment may find reason to worry, because the risk mitigation that works in other areas might not be as effective in this field.
-
In a ruling that has risk managers and attorneys across the country watching for repercussions, the Supreme Court of Washington state recently ruled that requiring a certificate of merit for a medical malpractice case is unconstitutional.
-
The role of statins in treatment of dyslipidemia is well established. There are, however, limitations of statins: Residual risk is substantial, not all persons can tolerate statins, and, even with full-dose statin treatment, some patients do not achieve lipid goals.
-
-
FDA is reviewing safety of TZDs; SSRI use with tamoxifen; Metformin smells like fish; FDA Actions.